Back

eMedEd

  • Immunoconjugates
  • Papillomavirus Infections
  • Papillomavirus Vaccines
  • Uterine Cervical Neoplasms
  • Vaccination

Advancements in HPV-Related Cancer Prevention and Treatment: Integrating Vaccination, Screening, and Therapeutic Innovations

This CME course offers a comprehensive exploration of HPV-related cancers, with a particular focus on the prevention, diagnosis, and treatment of cervical cancer. Participants will gain a detailed understanding of the high-risk HPV strains responsible for cancers of the cervix, vulva, vagina, anus, and oropharynx, and learn how persistent HPV infection drives oncogenesis. The course emphasizes evidence-based prevention strategies, including the HPV vaccine, tailored screening protocols, and the growing role of self-administered HPV testing in early detection. Learners will also review cutting-edge therapeutic innovations such as immunotherapy, PARP inhibitors, and antibody-drug conjugates that are transforming outcomes for patients with cervical cancer. By the end of the course, clinicians will be equipped to implement personalized care plans aligned with current NCCN guidelines, effectively integrating preventive measures and emerging treatments to reduce the burden of HPV-related cancers across diverse populations.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

$25

Standard

Listed by the provider · emedevents.com

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • $25
  • Released
    Apr 18, 2025
  • Last day to claim credit
    Dec 1, 2026 7 weeks left